The patent EP4324851B1 was granted to Regeneron Pharmaceuticals on Aug 27, 2025 following the initial filing on Jul 18, 2019 under the application number EP23215003A . The current legal status of the patent is Granted And Under Opposition.
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents